Publisher
Springer Science and Business Media LLC
Reference25 articles.
1. Cruz CR, Bollard CM. T-cell and natural killer cell therapies for hematologic malignancies after hematopoietic stem cell transplantation: enhancing the graft-versus-leukemia effect. Haematologica. 2015;100:709–19.
2. Dierckx de Casterlé I, Billiau AD, Sprangers B. Recipient and donor cells in the graft-versus-solid tumor effect: It takes two to tango. Blood Rev. 2018;32:449–56.
3. Barkholt L, Bregni M, Remberger M, Blaise D, Peccatori J, French ITAC group and the EBMT Solid Tumour Working Party, et al. Allogeneic haematopoietic stem cell transplantation for metastatic renal carcinoma in Europe. Ann Oncol. 2006;17(1134):1140.
4. Bishop MR, Fowler DH, Marchigiani D, Castro K, Kasten-Sportes C, et al. Allogeneic lymphocytes induce tumor regression of advanced metastatic breast cancer. J Clin Oncol. 2004;22:3886–92.
5. Takahashi T, Omuro Y, Matsumoto G, Sakamaki H, Maeda Y, et al. Nonmyeloablative allogeneic stem cell transplantation for patients with unresectable pancreatic cancer. Pancreas. 2004;28:e65–9.